Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (421-430 of 706) with videos related to

Pageof 71
Sort By:
JAMA Cardiology|August 25, 2021
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary SyndromeGorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck, et al.
Journal of the American College of Cardiology|July 18, 2006
Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgeryRajendra H Mehta, Matthew T Roe, Jyotsna Mulgund, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2004
Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque ruptureC Michael Gibson, Ajay J Kirtane, Sabina A Murphy, et al.
Diabetes, Obesity & Metabolism|November 17, 2022
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozinKaren D Corbin, Samuel Dagogo-Jack, Christopher P Cannon, et al.
Kidney Diseases (Basel, Switzerland)|March 3, 2025
Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV TrialDavid Z I Cherney, Robert Frederich, Richard E Pratley, et al.
American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.
Circulation|December 17, 2008
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attackLee H Schwamm, Gregg C Fonarow, Mathew J Reeves, et al.
Annals of Internal Medicine|August 4, 2004
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach, Christopher P Cannon, William S Weintraub, et al.
American Heart Journal|September 2, 2008
Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE)Deepu Alexander, Fang-Shu Ou, Matthew T Roe, et al.
Clinical Cardiology|June 30, 2012
Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery diseaseHector M Medina, Christopher P Cannon, Gregg C Fonarow, et al.
Pageof 71

Showing results (421-430 of 706) with videos related to

Sort By:
Pageof 71
JAMA Cardiology|August 25, 2021
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary SyndromeGorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck, et al.
Journal of the American College of Cardiology|July 18, 2006
Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgeryRajendra H Mehta, Matthew T Roe, Jyotsna Mulgund, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2004
Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque ruptureC Michael Gibson, Ajay J Kirtane, Sabina A Murphy, et al.
Diabetes, Obesity & Metabolism|November 17, 2022
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozinKaren D Corbin, Samuel Dagogo-Jack, Christopher P Cannon, et al.
Kidney Diseases (Basel, Switzerland)|March 3, 2025
Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV TrialDavid Z I Cherney, Robert Frederich, Richard E Pratley, et al.
American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.
Circulation|December 17, 2008
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attackLee H Schwamm, Gregg C Fonarow, Mathew J Reeves, et al.
Annals of Internal Medicine|August 4, 2004
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach, Christopher P Cannon, William S Weintraub, et al.
American Heart Journal|September 2, 2008
Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE)Deepu Alexander, Fang-Shu Ou, Matthew T Roe, et al.
Clinical Cardiology|June 30, 2012
Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery diseaseHector M Medina, Christopher P Cannon, Gregg C Fonarow, et al.
Pageof 71